SLCO2A1 and diabetic foot: In contrast, diabetes patients with diabetic foot ulcers have locally upregulated expression of SLCO2A1 and, consequently, have highly reduced extracellular PGE2 levels associated with impaired wound healing due to inability to activate EP4 receptors (Syeda et al., 2012).